Fundraising Fox
CIPRA.ai
Techstars '25San Diego, US · Founded 2022 · 15 employees on LinkedIn · 1 known investors
Find your way into CIPRA.ai
Sign up to see every warm intro you have to CIPRA.ai
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CIPRA.ai team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CIPRA.ai develops an AI-based platform for precise diagnosis and management of chronic conditions including hypertension and diabetes for patients and health systems. The platform uses data-driven approaches to identify relationships between lifestyle factors and chronic disease outcomes.
Also known as CIPRA · CIPRA.ai, Inc.
Founders & leadership
CIPRA.ai was founded in 2022 by Sujit Dey, Jared Leitner, and PoHan Chiang.
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026CIPRA.ai is a San Diego-based digital health company offering an AI-driven chronic care management platform for conditions such as hypertension and diabetes. The platform combines continuous sensing from connected devices, a patient-specific digital twin, AI health agents and a clinical team of nurses and clinicians into what the company calls a virtual care provider for precision medicine. Data sources span blood pressure monitors, glucometers and CGMs, cardiac monitoring such as Holter devices, activity, sleep, nutrition, medication adherence, patient-reported symptoms and questionnaires, contextual behavior data, and EHR records including labs and clinical history.
The consumer-facing CIPRA.ai mobile application ingests lifestyle data from wearables such as Fitbit and readings from at-home monitors such as Omron and iHealth, then runs a personalized AI analysis to identify the lifestyle factors with the greatest positive or negative influence on a user's blood pressure or blood glucose. It provides weekly progress updates against personalized targets, interactive trend graphs, short daily questionnaires covering stress, mood and diet, medication and weight logging, and optional push notifications for new recommendations. The Android app has recorded 500+ downloads and was last updated in August 2026.
The company states it is developing its own medical wearable, described as purpose-built for AI-driven precision care rather than fitness tracking, with continuous cuffless blood pressure monitoring, passive data collection, motion and activity analysis, heart health, sleep and stress monitoring, and direct access to raw sensor data without a third-party intermediary. The wearable is guided by, and feeds data back into, each patient's digital twin.
Business model
CIPRA.ai operates as a virtual care provider, delivering an AI-supported chronic care program alongside its own clinical staff to healthcare organizations and their patient populations, and distributing a patient-facing mobile application. It offers programs addressed to providers seeking between-visit chronic care without adding staff, ACOs managing attributed lives, participants in the CMS ACCESS model, and payors and TPAs.
Traction
The company reports 85%+ weekly patient engagement (patients taking readings and completing check-ins), a 3x improvement in control rates versus usual care, and a 40x reduction in clinical workload, stated as validated through clinical research and live healthcare deployments. Its Android application has surpassed 500 downloads. Published patient testimonials describe blood pressure improvements, including one from 150/80 to 115/68 over five months.
Latest developments
In September 2026 the company announced a collaboration with Murata on AI-powered health wearables. In 2025 it joined the Techstars Healthcare Accelerator powered by Permanente Medicine and was named among the ten startups in Techstars' first Washington, DC healthcare accelerator cohort. A CIPRA medical wearable is listed as coming soon.
▸Full profile — market position, technology, go-to-market, geography, risks & controversies
Market position
An early-stage chronic care management company working with named healthcare partners including Durga Madala Cardiology and Blossom Ridge Medical Group, and selected into the first Techstars healthcare accelerator cohort in Washington, DC.
The company positions its approach against reactive, one-size-fits-all care and against consumer fitness trackers, emphasizing patient-specific digital twins that pinpoint highest-impact interventions, predictive identification of risks before clinical events, and a purpose-built medical wearable providing direct access to raw sensor data.
Technology
The platform layers holistic multimodal sensing (physiological, behavioral, nutritional, patient-reported and EHR data), a per-patient digital twin that identifies key drivers of a condition and forecasts emerging risks, agentic AI health agents that engage patients, monitor progress and escalate to clinicians, and an orchestration layer the company terms Clinical Physical AI that balances AI and clinician action. A proprietary medical wearable for continuous blood pressure and cardiac, sleep and stress monitoring is announced as forthcoming.
Go-to-market
Direct engagement with healthcare organizations through demo requests, with segmented offerings for providers, ACOs, CMS ACCESS participants, and payors/TPAs; a consumer app distributed via Google Play; and participation in the Techstars Healthcare Accelerator powered by Permanente Medicine.
Patients with hypertension and diabetes; medical practices and providers; accountable care organizations; organizations participating in the CMS ACCESS model; payors and third-party administrators.
Geography
Headquartered in San Diego, California (4458 Philbrook Sq, San Diego, CA 92130), with accelerator participation in Washington, DC.
Risks & controversies
Reported outcome and engagement figures are company-stated and not independently documented in the available material; the medical wearable is not yet released.
Compiled by commissioned research from 4 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Related companies · 1
Companies working in the same space as CIPRA.ai.
Timeline · 4
launches, deals, and filingsCIPRA.ai announced a collaboration with Murata to advance AI-powered health wearables.
The CIPRA.ai Android app, which analyzes wearable and home-monitor data to identify top lifestyle factors affecting blood pressure and blood glucose, was updated.
CIPRA.ai was included in the ten-startup cohort of Techstars' first healthcare accelerator in Washington, DC.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 4
primary sources listed
- CIPRA.aicipra.ai · web
4 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does CIPRA.ai do?
- CIPRA.ai is a virtual care provider using medical wearables, patient digital twins and AI agents for chronic care management.
- Who founded CIPRA.ai?
- CIPRA.ai was founded by Sujit Dey, Jared Leitner, PoHan Chiang in 2022.
- Who are CIPRA.ai's investors?
- CIPRA.ai's investors include Techstars.
- Where is CIPRA.ai headquartered?
- CIPRA.ai is headquartered in San Diego, US.